Acceptability of a nipple shield delivery system administering antiviral agents to prevent mother-to-child transmission of HIV through breastfeeding

listen audio

Study Justification:
– Breastfeeding is a route of mother-to-child transmission (MTCT) of HIV.
– Antiretroviral (ARV) prophylaxis is recommended to prevent MTCT during breastfeeding.
– The nipple shield delivery system (NSDS) is being developed as an accessible method to deliver ARVs to infants.
– The NSDS can potentially overcome hygiene and storage issues in low-resource settings.
Study Highlights:
– Conducted focus group discussions and in-depth interviews with HIV-positive mothers, grandmothers/mothers-in-law, fathers/husbands, and maternal/child health care providers.
– Explored acceptability, safety, effectiveness, and feasibility of the NSDS.
– Participants expressed trust in the NSDS if scientifically validated and promoted by health care professionals.
– Identified HIV-related stigma, access, efficacy, and hygiene as important considerations for acceptance.
– Concluded that the NSDS is a potentially acceptable method for PMTCT during breastfeeding.
– Recommended further studies to confirm acceptability, safety, and efficacy.
– Highlighted the need for strategies to minimize HIV-related stigma and ensure continuous hygiene of the device.
Recommendations for Lay Reader and Policy Maker:
– The NSDS shows promise as a method to prevent mother-to-child transmission of HIV during breastfeeding.
– Further research is needed to validate the acceptability, safety, and effectiveness of the NSDS.
– Strategies should be developed to address HIV-related stigma and ensure proper hygiene of the device.
Key Role Players:
– Researchers and scientists to conduct further studies on the NSDS.
– Health care professionals to promote and validate the NSDS.
– Policy makers to develop strategies to address HIV-related stigma and support the adoption of the NSDS.
Cost Items for Planning Recommendations:
– Research funding for further studies on the NSDS.
– Budget for training and education of health care professionals on the NSDS.
– Resources for developing and implementing strategies to address HIV-related stigma.
– Funding for the production and distribution of the NSDS in low-resource settings.

Background: Breastfeeding is a route of mother-to-child transmission (MTCT) of the human immunodeficiency virus (HIV). The World Health Organization recommends antiretroviral (ARV) prophylaxis as the best method to prevent mother-tochild transmission of HIV (PMTCT) during breastfeeding. The nipple shield delivery system (NSDS) is being developed as an accessible method to deliver ARVs to infants and PMTCT during breastfeeding. The NSDS can potentially circumvent hygiene and storage issues in delivering drugs to infants in low-resource settings. Objectives: The primary objective was to determine acceptability of the NSDS for PMTCT in Kenya. Secondary objectives included assessing mothers’ understanding of MTCT and identifying cultural and implementation issues that might affect NSDS acceptability. Methods: Eleven focus group discussions were conducted, each group consisting of 7 to 12 participants. Seven focus group discussions consisted of HIV-positive mothers, 2 included grandmothers/mothers-in-law, and 2 included fathers/husbands. Ten in-depth interviews were also conducted with individual maternal/child health care providers. Topics included infant feeding and HIV stigma, as well as safety, effectiveness, and feasibility of the NSDS. Device prototypes were used in discussions. Results: Participants felt that the NSDS could be trusted if validated scientifically and promoted by health care professionals. HIV-related stigma, access, efficacy, and hygiene were identified as important considerations for acceptance. Conclusion: The NSDS is a potentially acceptable method of PMTCT during breastfeeding. Further studies are needed to confirm acceptability, safety, and efficacy. For NSDS adoption to PMTCT, strategies will need to be developed to minimize HIV-related stigma and to ensure that continuous hygiene of the device is maintained.

Innovation Recommendation: The development and promotion of a nipple shield delivery system (NSDS) to administer antiviral agents for preventing mother-to-child transmission of HIV through breastfeeding.

Description: The NSDS is being developed as an accessible method to deliver antiretroviral (ARV) prophylaxis to infants during breastfeeding. It aims to address hygiene and storage issues in low-resource settings. This study conducted focus group discussions and interviews to assess the acceptability of the NSDS for preventing mother-to-child transmission (PMTCT) in Kenya.

Findings: Participants expressed trust in the NSDS if scientifically validated and promoted by healthcare professionals. Factors such as HIV-related stigma, access, efficacy, and hygiene were identified as important considerations for acceptance. The study concluded that the NSDS has the potential to be an acceptable method for PMTCT during breastfeeding, but further studies are needed to confirm its acceptability, safety, and efficacy. Strategies to minimize HIV-related stigma and ensure device hygiene will be crucial for its adoption.

Overall, the NSDS represents an innovative approach to improve access to maternal health by providing a convenient and effective method for delivering ARVs to infants during breastfeeding, particularly in low-resource settings.
AI Innovations Description
The recommendation to improve access to maternal health is the development and implementation of a nipple shield delivery system (NSDS) for administering antiviral agents to prevent mother-to-child transmission (MTCT) of HIV through breastfeeding. The NSDS is being developed as an accessible method to deliver antiretroviral (ARV) prophylaxis to infants during breastfeeding, which is recommended by the World Health Organization for PMTCT.

The acceptability of the NSDS for PMTCT in Kenya was assessed through focus group discussions and interviews with HIV-positive mothers, grandmothers/mothers-in-law, fathers/husbands, and maternal/child health care providers. The participants expressed trust in the NSDS if it is scientifically validated and promoted by healthcare professionals. They identified HIV-related stigma, access, efficacy, and hygiene as important considerations for acceptance.

Based on the findings, it was concluded that the NSDS is a potentially acceptable method for PMTCT during breastfeeding. However, further studies are needed to confirm its acceptability, safety, and efficacy. Strategies will also need to be developed to minimize HIV-related stigma and ensure continuous hygiene of the device for successful adoption of the NSDS in PMTCT.

Overall, the recommendation is to continue the development and evaluation of the NSDS as an innovative solution to improve access to maternal health by preventing MTCT of HIV through breastfeeding.
AI Innovations Methodology
In order to improve access to maternal health, one potential innovation recommendation is the use of a nipple shield delivery system (NSDS) to administer antiviral agents for preventing mother-to-child transmission of HIV through breastfeeding. The NSDS is being developed as an accessible method to deliver antiretroviral (ARV) prophylaxis to infants, addressing hygiene and storage issues in low-resource settings.

To simulate the impact of this recommendation on improving access to maternal health, a methodology could be implemented as follows:

1. Study Design: Conduct a mixed-methods study involving focus group discussions and in-depth interviews to gather data on the acceptability, safety, and efficacy of the NSDS for preventing mother-to-child transmission of HIV during breastfeeding.

2. Participant Selection: Recruit HIV-positive mothers, grandmothers/mothers-in-law, fathers/husbands, and maternal/child health care providers from diverse backgrounds and regions in Kenya to ensure a representative sample.

3. Data Collection: Conduct eleven focus group discussions, each consisting of 7 to 12 participants, to explore participants’ understanding of mother-to-child transmission of HIV, assess their acceptance of the NSDS, and identify cultural and implementation issues that may affect its acceptability. Additionally, conduct ten in-depth interviews with individual maternal/child health care providers to gather their perspectives on the NSDS.

4. Discussion Topics: Cover a range of topics in the focus group discussions and interviews, including infant feeding and HIV stigma, safety, effectiveness, and feasibility of the NSDS. Use device prototypes during the discussions to facilitate understanding and feedback.

5. Data Analysis: Analyze the qualitative data collected from the focus group discussions and interviews using thematic analysis to identify common themes, patterns, and insights related to the acceptability of the NSDS.

6. Recommendations and Strategies: Based on the findings, develop recommendations and strategies to address HIV-related stigma, access, efficacy, and hygiene concerns associated with the NSDS. These recommendations should aim to minimize stigma and ensure continuous hygiene of the device.

7. Further Studies: Acknowledge the need for further studies to confirm the acceptability, safety, and efficacy of the NSDS. Consider conducting larger-scale trials or pilot programs to assess the real-world impact of implementing the NSDS for preventing mother-to-child transmission of HIV during breastfeeding.

By following this methodology, researchers can gain valuable insights into the acceptability of the NSDS and develop strategies to improve access to maternal health by addressing the identified barriers and concerns.

Yabelana ngalokhu:
Facebook
Twitter
LinkedIn
WhatsApp
Email